Common Contracts
2 similar License Agreement contracts by Versartis, Inc.
EX-10.7 8 d568658dex107.htm EX-10.7 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 406 of the Securities Exchange Act of 1933, as amended. A complete copy of this document has been...License Agreement • May 5th, 2020
This license agreement (“Agreement”), effective as of December 1, 2017 (“Effective Date”) is entered and made by and between WuXi Biologics (Hong Kong) Limited, having an address at Suite 3701-10, 37F, Jardine Hse, 1 Connaught Place, Central Hong Kong (“WuXi Biologics”) and Aravive Biologics, Inc., having its principal place of business at 1221 McKinney Street, Suite 3200, Houston, Texas 77010 (“Licensee”).
LICENSE AGREEMENTLicense Agreement • August 3rd, 2018 • Versartis, Inc. • Pharmaceutical preparations
This license agreement (“Agreement”), effective as of December 1, 2017 (“Effective Date”) is entered and made by and between WuXi Biologics (Hong Kong) Limited, having an address at Suite 3701-10, 37F, Jardine Hse, 1 Connaught Place, Central Hong Kong (“WuXi Biologics”) and Aravive Biologics, Inc., having its principal place of business at 1221 McKinney Street, Suite 3200, Houston, Texas 77010 (“Licensee”).
